<DOC>
	<DOCNO>NCT02207868</DOCNO>
	<brief_summary>The aim study document leave right ventricular function patient sclerodermia associate pulmonal arterial hypertension via 3D echocardiography . The result study help generate hypothesis future study . The primary hypothesis increase use modern image guide method could provide essential aspect follow .</brief_summary>
	<brief_title>3D Echo Evaluation Ventricles Sclero Associated Severe PAH</brief_title>
	<detailed_description>The 3D echocardiography could provide early detailed information change leave right ventricle . The prediction sclerodermia associate pulmonary arterial hypertension ( PAH ) rather adverse , make sense evaluate relevant change left-ventricular longitudinal strain soon adapt PAH specific therapy accordingly .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>age &gt; 17 pulmonary arterial hypertension ( PAH ) associate WHO group 1 start parenteral prostanoidtherapy write informed consent prostanoid naive change PAH specific therapy within 3 week recruitment study pregnancy lactation period Women child bear potential use effective secure method birth control severe chronic kidney insufficiency ( glomerular filtration rate &lt; 30 ) , remain 3 month liverinsufficiency Child C life expectancy short course study ( example malignant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>